Alfa Cytology aims to use the patient's immune system to find and destroy brain tumor cells or to help activate the immune system through the patient's dendritic cells (DC) to fight cancer. We hope that vaccine will carry specific antigenic information extracted from post-operative tumor tissue and deliver it to T cells after injection to stimulate tumor-killing activity. Thus, we can achieve your desired goal of prolonging the patient's survival and improving the quality of life.Alfa Cytology provides services on <a href="https://www.alfaoncology.com/brain-tumors/vaccine-development-services-for-brain-tumors.html">brain tumor immunotherapy</a>.
by toyatang
Alfa Cytology identifies unique cancer-carrying genes by sequencing tumor cell genes, predicts immune presentation affinity, and then screens out unique neoantigens encoded by cancer-carrying genes. Our goal is to use neoantigens to target various cancers, such as developing neoantigen vaccines and related targeted therapies, thereby making a huge contribution to tumor immunotherapy. Alfa Cytology provides neoantigen services.
by toyatang